• PolyPid (PYPD) The Citizens Life Sciences Conference 2026 Summary Quartr Thu, 09 Jul 2026 17:10:03 GMT
• PolyPid (PYPD) Lytham Partners Spring 2026 Investor Conference Summary Quartr Thu, 09 Jul 2026 17:05:38 GMT
• PolyPid Ltd stock and its pipeline. A closer look at the drug-delivery specialist AD HOC NEWS Fri, 03 Jul 2026 19:28:42 GMT
• enterprise value to revenue forward of polypid ltd. – nasdaq:pypd TradingView Thu, 02 Jul 2026 04:31:06 GMT
• PYPD Q1 2026 Earnings: Narrowed Loss Beats Estimates as Pipeline Progress Continues - Cash Flow Report dars.gov.et Sat, 27 Jun 2026 07:00:00 GMT
• lilly’s $780m bet is reshaping surgical infection prevention, and polypid’s asset is hiding in plain sight TipRanks Thu, 25 Jun 2026 19:35:46 GMT
• polypid ltd (pypd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 25 Jun 2026 12:23:05 GMT
• pypd q1 2026 earnings: eps beat by 20.8% as company advances d-plex platform - return on equity dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• roth mkm maintains polypid(pypd.us) with buy rating, raises target price to $9 Moomoo Fri, 19 Jun 2026 17:58:59 GMT
• polypid ltd (pypd) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 23:54:39 GMT
• polypid ltd (pypd) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 22:54:59 GMT
• PolyPid Ltd (PYPD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 21:36:18 GMT
• polypid ltd (pypd) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:57:54 GMT
• polypid ltd (pypd) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:53:03 GMT
• polypid ltd (pypd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:50:49 GMT
• polypid ltd (pypd) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 09:26:48 GMT
• polypid ltd (pypd) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 09:23:10 GMT
• polypid ltd stock (us70450b1035): modest move as market awaits next catalyst AD HOC NEWS Tue, 16 Jun 2026 20:36:46 GMT
• polypid ltd (pypd) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• polypid ltd. (pypd) stock price | live quotes & charts | nasdaq StocksToTrade Mon, 15 Jun 2026 13:40:56 GMT
• PYPD Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline - Retail Earnings Report dars.gov.et Mon, 15 Jun 2026 07:00:00 GMT
• polypid ltd. (pypd) shares edge higher as support holds, resistance in focus - trin signal newsline.com Sun, 14 Jun 2026 00:46:08 GMT
• [6-k] polypid ltd. current report (foreign issuer) | pypd sec filing - form 6-k Stock Titan Wed, 10 Jun 2026 20:01:24 GMT
• PolyPid (PYPD) schedules July 15, 2026 meeting on director, auditor and option approvals Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• polypid sets july 15, 2026 shareholder meeting to vote on board, auditor and equity grants TipRanks Wed, 10 Jun 2026 07:00:00 GMT
• polypid schedules annual and extraordinary shareholder meeting for july 15 Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• When Can We Expect A Profit From PolyPid Ltd. (NASDAQ:PYPD)? simplywall.st Mon, 08 Jun 2026 07:00:00 GMT
• pypd q1 2026 earnings: narrower-than-expected loss drives 20.81% surprise; shares dip despite progress - forward eps estimate newsline.com Mon, 08 Jun 2026 06:41:46 GMT
• polypid ltd. (pypd) shares slide 6.8% as stock approaches key support at $4.27 - factor valuation newsline.com Sat, 06 Jun 2026 00:42:48 GMT
• pypd q1 2026 earnings: pre-revenue biotech narrows loss, stock slides on no commercial milestones - quarterly financial update newsline.com Fri, 05 Jun 2026 18:42:32 GMT
• polypid ltd. (pypd) shares slide 6.8% as stock approaches key support at $4.27 - channel projection newsline.com Fri, 05 Jun 2026 07:00:00 GMT
• pypd q1 2026 earnings: narrower loss surprises as key pipeline progress remains on track - guidance accuracy score newsline.com Thu, 04 Jun 2026 12:34:10 GMT
• polypid stock barely moves after fda filing, but a 2027 decision now looms Bez Kabli Thu, 04 Jun 2026 07:00:00 GMT
• PYPD Q1 2026 Earnings: Narrower Than Expected Loss Drives Positive Surprise Despite Stock Dip - Revenue Per Share dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• PolyPid Completes FDA NDA Submission for D-PLEX100 in Surgical Site Infection Prevention Contagion Live Tue, 02 Jun 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: revolution medicines (rvmd), in8bio (inab) and polypid (pypd) The Globe and Mail Tue, 02 Jun 2026 07:00:00 GMT
• roth mkm maintains polypid(pypd.us) with buy rating, raises target price to $9 Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• PolyPid (Nasdaq: PYPD) files FDA NDA for D-PLEX100 infection drug Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀ GlobeNewswire Mon, 01 Jun 2026 07:00:00 GMT
• PolyPid completes NDA submission for surgical infection drug Investing.com Mon, 01 Jun 2026 07:00:00 GMT
• new surgical infection drug from polypid heads to fda decision in 2027 Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• polypid completes rolling nda submission to fda for d-plex100 marketscreener.com Mon, 01 Jun 2026 07:00:00 GMT
• polypid files nda with fda for lead infection-prevention drug d-plex100 TipRanks Mon, 01 Jun 2026 07:00:00 GMT
• polypid ltd stock (us70450b1035): nasdaq-listed biotech sees quiet trading as investors await next c Ad-hoc-news.de Mon, 01 Jun 2026 07:00:00 GMT
• pypd q1 2026 earnings: narrower-than-expected loss drives positive stock reaction - estimate revision count newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• polypid q1 2026 earnings: narrower-than-expected loss highlights progress in d-plex development - earnings acceleration picks newsline.com Sat, 30 May 2026 07:00:00 GMT
• pypd q1 2026 earnings: narrower net loss beats expectations as clinical pipeline advances - net profit margin newsline.com Sat, 30 May 2026 07:00:00 GMT
• polypid ltd. (pypd) q1 2026 earnings: narrower-than-expected loss on strong expense control - guidance downgrade alert newsline.com Fri, 29 May 2026 07:00:00 GMT
• polypid ltd. (pypd) edges lower, testing key support near $4.52 - delta hedging The Legal Advocate Fri, 29 May 2026 00:38:26 GMT
• polypid ltd. (pypd) edges lower, testing key support near $4.52 - rating change newsline.com Thu, 28 May 2026 07:00:00 GMT
• pypd q1 2026 earnings: narrower-than-expected loss as clinical pipeline advances - final results newsline.com Thu, 28 May 2026 07:00:00 GMT
• polypid shares edge lower as stock nears key support zone - short term trading ideas thelegaladvocate.com Wed, 27 May 2026 18:31:31 GMT
• polypid shares slide amid light trading, testing key support levels (pypd) - momentum trade The Legal Advocate Tue, 26 May 2026 15:38:33 GMT
• polypid (pypd) jumps 3.93% as stock approaches key resistance level - bull pennant newsline.com Fri, 22 May 2026 07:00:00 GMT
• pypd q1 2026 earnings: eps beat on operational discipline, but revenue remains absent - one-time loss impact The Legal Advocate Fri, 22 May 2026 07:00:00 GMT
• polypid to participate in the craig-hallum 23rd annual institutional investor conference GlobeNewswire Wed, 20 May 2026 07:00:00 GMT
• polypid (pypd) q1 2026 earnings: why the beat matters - weak earnings momentum newsline.com Tue, 19 May 2026 07:00:00 GMT
• polypid ltd stock (us70450b1035): pivotal phase 3 data and nasdaq listing shift in focus AD HOC NEWS Sun, 17 May 2026 13:36:05 GMT
• h.c. wainwright maintains polypid(pypd.us) with buy rating, maintains target price $13 富途牛牛 Sat, 16 May 2026 06:10:54 GMT
• polypid advances d-plex100 regulatory strategy following q1 results HarianBasis.co Fri, 15 May 2026 07:04:18 GMT
• polypid (pypd) q1 2026 earnings: eps $-0.35 beats estimates - dividend growth analysis newsline.com Fri, 15 May 2026 07:00:00 GMT
• polypid submits d-plex100 new drug application to fda HarianBasis.co Fri, 15 May 2026 05:58:18 GMT
• polypid ltd. (nasdaq:pypd) q1 2026 earnings call transcript Insider Monkey Thu, 14 May 2026 07:00:00 GMT
• h.c. wainwright maintains polypid(pypd.us) with buy rating, maintains target price $13 Moomoo Thu, 14 May 2026 07:00:00 GMT
• roth mkm maintains polypid(pypd.us) with buy rating, maintains target price $9 Moomoo Thu, 14 May 2026 07:00:00 GMT
• polypid stock (us70450b1035): nda submission advances d-plex100 toward fda review AD HOC NEWS Thu, 14 May 2026 07:00:00 GMT
• pypd earning date, earning analysis and earning prediction Intellectia AI Thu, 14 May 2026 02:02:26 GMT
• earnings call transcript: polypid’s q1 2026 earnings beat expectations, stock rises Investing.com Wed, 13 May 2026 13:53:12 GMT
• polypid reports reduced first quarter losses and advances fda submission HarianBasis.co Wed, 13 May 2026 13:41:52 GMT
• polypid ltd reports results for the quarter ended december 31 - earnings summary TradingView Wed, 13 May 2026 13:31:50 GMT
• polypid ltd. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Wed, 13 May 2026 11:30:00 GMT
• PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• [6-K] PolyPid Ltd. Current Report (Foreign Issuer) | PYPD SEC Filing - Form 6-K Stock Titan Wed, 13 May 2026 07:00:00 GMT
• Drug for post-surgery infections enters FDA review after 64% risk reduction Stock Titan Wed, 13 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: dyadic international (dyai), polypid (pypd) and mdxhealth (mdxh) The Globe and Mail Wed, 13 May 2026 07:00:00 GMT
• pypd: nda submission for d-plex100 nears completion as financials improve and commercialization advances TradingView Wed, 13 May 2026 07:00:00 GMT
• press release: polypid provides corporate update and reports first quarter 2026 financial results Moomoo Wed, 13 May 2026 07:00:00 GMT
• polypid ltd (pypd) q1 2026 earnings call highlights: strategic advances amid financial challenges by gurufocus Investing.com Canada Wed, 13 May 2026 07:00:00 GMT
• rosalind advisors/fund report 9.9% in polypid (pypd) via warrants and shares Stock Titan Tue, 12 May 2026 07:00:00 GMT
• polypid ltd expected to post a loss of 43 cents a share - earnings preview TradingView Mon, 11 May 2026 13:37:07 GMT
• how sustainable is polypid (pypd) profit margins? (smart money exits) 2026-05-08 - stock analysis Newser Fri, 08 May 2026 07:00:00 GMT
• polypid ltd. (nasdaq:pypd) receives consensus rating of "moderate buy" from analysts MarketBeat Fri, 08 May 2026 07:00:00 GMT
• polypid (pypd.us) will release its earnings report before the market opens on may 13. Moomoo Fri, 08 May 2026 01:00:27 GMT
• polypid (pypd.us) will release its earnings report before the market opens on may 13. Moomoo Thu, 07 May 2026 07:00:00 GMT
• PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026 GlobeNewswire Wed, 06 May 2026 07:00:00 GMT
• PolyPid to Announce First Quarter 2026 Financial Results on May 13 and Host Conference Call at 8:30 AM ET geneonline.com Wed, 06 May 2026 07:00:00 GMT
• Aurum holds 5,001,561 shares in Polypid Ltd. (PYPD) with exercisable warrants Stock Titan Mon, 04 May 2026 07:00:00 GMT
• aigh capital management llc has $5.83 million stock position in polypid ltd. $pypd MarketBeat Sat, 02 May 2026 07:00:00 GMT
• pypd polypid posts wider than expected q4 2025 loss yet shares gain two percent following its latest earnings release. - quarterly... The Legal Advocate Wed, 29 Apr 2026 07:00:00 GMT
• Press Release: PolyPid to Present Data From SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at S... Moomoo Tue, 28 Apr 2026 07:00:00 GMT
• polypid to present data from shield ii phase 3 trial demonstrating reduced severity of surgical site infection at surgical infecti... BioSpace Tue, 28 Apr 2026 07:00:00 GMT
• polypid says late-stage surgery trial cut severe wound infections 64% Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• polypid to present wound infection data at surgery conference Investing.com Tue, 28 Apr 2026 07:00:00 GMT
• pypd price today: polypid ltd. stock price, quote & chart | mexc MEXC Exchange Mon, 27 Apr 2026 07:27:46 GMT
• short interest in polypid ltd. (nasdaq:pypd) increases by 166.1% MarketBeat Sun, 26 Apr 2026 05:55:07 GMT
• polypid (pypd) stock outlook | q4 2025: earnings underperform - stock trading network Xã Vĩnh Công Thu, 23 Apr 2026 10:31:29 GMT
• pypd (polypid ltd. ordinary shares) reports wider than expected q4 2025 loss, yet shares rise modestly in today’s trading. - pro t... Cổng thông tin điện tử tỉnh Tây Ninh Thu, 23 Apr 2026 04:53:39 GMT
• polypid (pypd) stock outlook | q4 2025: earnings underperform - stock trading network Cổng thông tin điện tử Tỉnh Sơn La Wed, 22 Apr 2026 20:38:49 GMT
• polypid ltd stock (us70450b1035): is its drug-delivery tech strong enough to unlock biotech upside? AD HOC NEWS Tue, 21 Apr 2026 03:53:01 GMT
• polypid ltd stock (us70450b1035): is its drug delivery tech strong enough to unlock surgical market AD HOC NEWS Sat, 18 Apr 2026 09:23:47 GMT
• pypd (polypid ltd. ordinary shares) reports wider than expected q4 2025 loss, yet shares rise modestly in today’s trading. - earni... newsline.com Sat, 18 Apr 2026 07:00:00 GMT
• polypid (pypd) stock recovery underway (-1.27%) 2026-04-16 - rip sell trade newsline.com Thu, 16 Apr 2026 07:00:00 GMT
• polypid (pypd) stock outlook | q4 2025: earnings underperform - new analyst coverage The Legal Advocate Wed, 15 Apr 2026 07:00:00 GMT
• polypid to present phase 3 shield ii data showing sustained local doxycycline release and minimal systemic exposure at escmid 2026... Sahm Tue, 14 Apr 2026 12:53:48 GMT
• polypid to present new phase 3 shield ii data demonstrating d-plex₁₀₀ sustained local release at escmid global 2026 BioSpace Tue, 14 Apr 2026 07:00:00 GMT
• roth mkm maintains polypid(pypd.us) with buy rating, maintains target price $9 Moomoo Tue, 14 Apr 2026 07:00:00 GMT
• polypid to present new phase 3 shield ii data on d-plex100 at escmid 2026 RTTNews Tue, 14 Apr 2026 07:00:00 GMT
• short covering: how much upside does polypid ltd have - 2026 key lessons & weekly high return stock forecasts baoquankhu1.vn Mon, 13 Apr 2026 07:24:44 GMT
• PolyPid to Present New Phase 3 SHIELD II Data Demonstrating GlobeNewswire Mon, 13 Apr 2026 07:00:00 GMT
• in a phase 3 surgery trial, polypid's antibiotic released for 32 days Stock Titan Mon, 13 Apr 2026 07:00:00 GMT
• polypid to present d-plex100 pharmacokinetic data at escmid global Investing.com Mon, 13 Apr 2026 07:00:00 GMT
• polypid ltd. (nasdaq:pypd) sees significant growth in short interest MarketBeat Mon, 13 Apr 2026 07:00:00 GMT
• polypid ltd. (nasdaq:pypd) receives consensus rating of "moderate buy" from analysts MarketBeat Mon, 13 Apr 2026 07:00:00 GMT
• polypid to present new phase 3 shield ii data demonstrating d-plex₁₀₀ sustained local release at escmid global 2026 Bitget Sun, 12 Apr 2026 22:18:08 GMT
PolyPid Ltd(NASDAQ:PYPD) 
PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) s...
Website: http://www.polypid.com
Founded: 2008
Full Time Employees: 57
CEO: Amir Weisberg
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends